We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App




MR-Guided Focused Ultrasound Relieves Pain from Bone Metastases

By MedImaging International staff writers
Posted on 02 Dec 2008
Physicians are evaluating new ways to use magnetic resonance imaging (MRI) and ultrasound to relieve some of the extreme pain resulting from cancer that has metastasized to the bones.

"Bone metastases are one of the most common causes of pain for cancer patients," said Dr. King Li, chair of the department of radiology at the Methodist Hospital (Houston, TX, USA) and lead investigator for the trial. "Unfortunately, current treatments to relieve this intense pain are very limited."

Typical painkilling or palliative treatment includes invasive surgery that many late-stage cancer patients cannot tolerate, radiation that damages more tissue than necessary, or nerve ablation. In this study, MRI technology was used to visualize the patient's anatomy and then aims focused ultrasound waves at the targeted tissue, using low-level heat to ablate, or destroy it, reducing or eliminating the pain. This new method of using MR-guided focused ultrasound (MRgFUS) may provide a completely non-invasive way to relieve pain, according to Dr. Li.

In earlier clinical studies performed in Europe, most of the patients reported pain relief within days of treatment. "This is an important trial because 90% of patients with a progressive form of breast cancer have bone metastases, and almost all patients with metastatic prostate cancer have tumors that spread to the bones," Dr. Li said.

MRI scanning allows the clinician to monitor and continuously modify the treatment in real time. Due to inherent structural characteristics of the bone tissue, it is possible to use a low level of heat and achieve the desired effect, while minimizing damage to adjacent tissue.

The U.S. Food and Drug Administration (FDA) approved this technology, MRgFUS, to treat uterine fibroids in 2004. This same technology has shown promising effectiveness and safety results in pain-palliation feasibility studies in patients who have in-bone metastases, and researchers hope to validate those results though this larger investigational trial.

Related Links:

Methodist Hospital


Ultrasound Needle Guidance System
SonoSite L25
Digital Color Doppler Ultrasound System
MS22Plus
High-Precision QA Tool
DEXA Phantom
Multi-Use Ultrasound Table
Clinton

Channels

Nuclear Medicine

view channel
Image: This artistic representation illustrates how the drug candidate NECT-224 works in the human body (Photo courtesy of HZDR/A. Gruetzner)

Radiopharmaceutical Molecule Marker to Improve Choice of Bladder Cancer Therapies

Targeted cancer therapies only work when tumor cells express the specific molecular structures they are designed to attack. In urothelial carcinoma, a common form of bladder cancer, the cell surface protein... Read more

Imaging IT

view channel
Image: The new Medical Imaging Suite makes healthcare imaging data more accessible, interoperable and useful (Photo courtesy of Google Cloud)

New Google Cloud Medical Imaging Suite Makes Imaging Healthcare Data More Accessible

Medical imaging is a critical tool used to diagnose patients, and there are billions of medical images scanned globally each year. Imaging data accounts for about 90% of all healthcare data1 and, until... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.